Evidence map›Paper›PMID 40076264›Full record

ArticleMolecules (Basel, Switzerland)2025

Bioactive Compounds with Leishmanicidal Potential from

Rachel Nápoles Rodríguez, María Laura Arreguez, Aldana M Corlatti, Hernán G Bach, César A N Catalán, Laura C Laurella, Paola A Barroso, Valeria P Sülsen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel Nápoles RodríguezCONICET-Universidad de Buenos Aires, Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Autonomous City of Buenos Aires C1113AAD, Argentina.ORCID 0009-0001-5901-9166
María Laura ArreguezCONICET-Universidad Nacional de Salta, Instituto de Patología Experimental (IPE), Salta A4400, Argentina.
Aldana M CorlattiCONICET-Universidad de Buenos Aires, Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Autonomous City of Buenos Aires C1113AAD, Argentina.ORCID 0009-0002-5603-8887
Hernán G BachInstituto Nacional de Tecnología Agropecuaria, Buenos Aires B1686, Argentina.
César A N CatalánInstituto de Química Orgánica, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, San Miguel de Tucumán, Tucumán T4000INI, Argentina.ORCID 0000-0001-7409-5303
Laura C LaurellaCONICET-Universidad de Buenos Aires, Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Autonomous City of Buenos Aires C1113AAD, Argentina.
Paola A BarrosoCONICET-Universidad Nacional de Salta, Instituto de Patología Experimental (IPE), Salta A4400, Argentina.ORCID 0000-0002-4406-2575
Valeria P SülsenCONICET-Universidad de Buenos Aires, Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Autonomous City of Buenos Aires C1113AAD, Argentina.ORCID 0000-0002-9322-5748

Funding

The National Agency for Science and Technology Promotion PICT 2020-03061University of Buenos Aires UBACYT 441 20020220300118BA
6 · The paper itself

Abstract

Leishmaniasis is a neglected tropical disease caused by protozoan parasites of the genus

Indexed as

Antiprotozoal AgentsAsteraceaeHelianthusLeishmaniaPlant ExtractsAnimalsLeishmaniasisMiceMice, Inbred BALB CSesquiterpenesAntiprotozoal AgentsPlant ExtractsSesquiterpenesAsteraceaein vitro and in vivo assaysLeishmania amazonensissesquiterpene lactones

Identifiers

PMID40076264
PMCPMC11901713

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.